Healthcare >> Analyst Interviews >> October 27, 2004

OUTLOOK FOR SPECIALTY PHARMACEUTICALS: ANGELA LARSON – C.E. UNTERBERG, TOWBIN

ANGELA LARSON is a Managing Director in the Equity Research Department at C.E. Unterberg, Towbin, where she covers the specialty pharmaceutical industry. Previously, she covered the same sector while part of the U.S. Equity Research Department at Smith Barney (2000-2004) and as an Analyst at PaineWebber (1997-2000). Prior to that, she was an Associate Analyst at PaineWebber with the US large cap pharmaceutical team. Prior to joining the Street, she worked in business development and was a Strategic Planning Analyst at Hoffman-La Roche. She has been mentioned in the Institutional Investor All-American Research Team polls for the last four years (number three in 2003 and 2002, number two in 2001 and 'Up and Comer' in 2000). She has an MS in Health Economics from Johns Hopkins University and a BA in Economics from Boise State University. Profile
TWST: Tell us about the conference that you put together.

Ms. Larson: The C.E. Unterberg, Towbin conference is a specialty

pharmaceutical focus conference that is really focused on the